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A B S T R A C T
This case concerns a 17-year-old boy, who was given the diagnosis of Alpers syndrome only postmortem
when a homozygous 1399G!A (A467T) mutation was found in the linker-region of POLG1. Serial muscle
and liver biopsies as well as brain MRI scans in our patient ranging from early childhood to postmortem
analyses showed that (i) routine diagnostic procedures can be normal in the early stage of the disorder
and that (ii) central nervous system and further organ affection may only develop in the time course of
the disease. Consecutive diagnostic examinations clearly reﬂected the devastating clinical course and
cerebral deterioration evolving over time in Alpers syndrome.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Infantile Alpers syndrome (OMIM 203700) is a severe
neurodegenerative disorder frequently associated with mitochon-
drial DNA polymerase g gene (POLG1) mutations.1–3 The syndrome
is clinically characterized by the triad of (a) refractory epilepsy, (b)
developmental delay, and (c) liver failure.
2. 2 Case report
A 17-year-old boy was referred to our Department of
Epileptology with refractory epilepsy and died three months later
in cerebral coma. He had developed normal until the age of ﬁve
years, when hewas ﬁrst admitted to hospital for status epilepticus.
Weeks later, he presented with cerebellar ataxia and myoclonus of
the left arm, evolving into epilepsia partialis continua. Skeletal
muscle biopsy at that time was non-contributory [no ragged red or
cytochrome c oxidase (COX)-negative ﬁbbers]. However, retro-
spectivemoleculargeneticwork-up of themuscle sample showed a
low amount of multiple mitochondrial (mt) DNA deletions (<5%)* Corresponding author at: University Hospital of Bonn, Department of
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doi:10.1016/j.seizure.2008.08.003and considerable mtDNA depletion (the meanmtDNA content was
reduced to 55% of 9 healthy controls aged 20.1  10.3 years) using
long-range and real-time PCR as previously described.4 The patient’s
condition gradually deteriorated over the years with progressive
cerebellar signs, cognitive decline from the age of 12, and worsening
of themyoclonus from the age of 15 years. Transient liver dysfunction
occurred under intermittent antiepileptic treatment with sodium
valproate. However, standard liver biopsy and magnetic resonance
imaging (MRI) of the brain at the age of 15 years were normal. At the
age of 17 years, the patient developed refractory focal motor status in
association with pneumonia ﬁnally requiring ventilatory assistance
and admission to our hospital. General anaesthesia, high dose
benzodiazepines, and phenobarbiturate did not interrupt the
intractable focal motor status. For successful seizure control,
treatment with sodium valproate was indispensable. Over the
following weeks, blood chemistries showed persistent mild (twofold)
elevated liver transaminase levels but no jaundice, hyperammonae-
mia, abnormalities of blood coagulation, or other signs of hepatic
failure. After three months of intubation, the patient remained in a
vegetative state after reduction of all anaesthetics maintaining
sodium valproate. A 1.5T brain MRI at that time showed symmetric
hyperintensities and swelling of deep grey matter nuclei as well as
cortical grey and subcortical whitematter with relative sparing of the
frontal cortex (Fig. 1). In the further clinical course, the patient
developed brainstem symptoms and died in coma one week after the
ﬁnal brain MRI examination. Autopsy showed a multiorgan failurevier Ltd. All rights reserved.
Fig. 1. Axial 5 mm thick FLAIR fast spin echo (A), T1-weighted spin echo (B), and diffusion-weighted spin echo EPI (C) at the level of the basal ganglia show hyperintense and
swollen deep grey matter nuclei as well as hyperintensity and swelling of the cortical grey and subcortical white matter. Note the nearly symmetric distribution and the fact
that the frontal cortex is rather spared (B, D).
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steatosis. Neuropathological examinations revealed spongiform
changes in the cerebrum, white matter spongiosis of the cerebellum,
a brainstem bleeding, and multiple lacunar ischaemic cortical
infarcts. Postmortem analyses of skeletal muscle and liver tissue
revealed massive mtDNA depletion. The mean mtDNA content in
muscle was reduced to 16% of controls, in liver to 10% of 5 normal
controls aged 53.5  1 years. Histology of postmortem liver tissue
showed abundant COX-negative areas with only isolated ﬁelds of
preserved COX-activity.5 The diagnosis of Alpers syndromewas given
postmortem, when a homozygous 1399G!A (A467T) mutation was
found in the linker-region of POLG1.
3. 3 Discussion
The phenotypic spectrum associated with POLG1 mutations is
wide and comprises progressive external ophthalmoplegia,6 ataxic
syndromes,7 progressive neurological disorders,8,9 and infantile
Alpers syndrome with mitochondrial DNA depletion.1,4 According
to recent data, the A467Tmutation can be detected in the majority
of childhood-onset cases associatedwith POLG1mutations.3 A467T
was recently found in 0.19% of German control alleles, providing a
reservoir for recessive disease.3 Previous reports on cerebralMRI in
Alpers syndrome taken months to years before death revealed
hyperintensities frequently located in occipital lobes, deep
cerebellar nuclei, thalamus, and basal ganglia.2,9,10 In contrast,MRI in our patient taken one week before death showed more
pronounced cortical and subcortical hyperintensities and swelling
similarly including deep grey matter nuclei. These ﬁndings were
more pronounced and only partly in line comparedwith previously
reported MRI patterns in Alpers syndrome. However, this is the
ﬁrst report on terminal brain MRI ﬁndings in a fatal disease course.
It may be speculative if the more generalized and severe signal
abnormalities in our patient are consequences of the natural
history of the disorder itself or due to the characteristic
complications of the disease like refractory status epilepticus.
Involvement of the deep grey internal nuclei, however, is not
consistent with prolonged status epilepticus. Therefore, these
ﬁndings can be interpreted as an expression of the terminal phase
of encephalopathy in this distinct mitochondrial disorder. Differ-
ential diagnostically, pronounced thalamic signal changes in MRI
can be present in general cerebral hypoxia, the variant of
Creutzfeld-Jakob disease, deep cerebral vein thrombosis, and
various mitochondrial disorders like infantile Leigh syndrome or
Kearns-Sayre syndrome. However, cerebral MRI pathology is
usually not restricted to deep grey internal or thalamic nuclei in
these disorders, which are usually easily to distinguish from Alpers
syndrome by clinical signs and symptoms.
Examination results of serial muscle samples taken at the age of
5 years and postmortem, liver biopsies taken at the age of 15 years
and postmortem, and brain MRI scans performed at 15 and 17
years of age prove the continuous and serious progress of cerebral
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our case demonstrates that brain MRI abnormalities in Alpers
syndrome may rapidly develop over a comparably short time
period and that muscle and liver biopsies following standard
histological procedures can be normal particularly in the early
course of the disease. Our experience underlines the impact of
serial MRI scans and the need for speciﬁc biopsy work-up in
clinically suspect patients including qualitative and quantitative
mtDNA examinations comprising analyses for multiple deletions
and/or depletion usually present in syndromes associated with
POLG1mutations. As POLG1mutationswere only recently reported
as frequent causes of infantile Alpers syndrome, deﬁnite numbers
of affected children are not known, and the diagnosis may easily be
overseen as many patients die at young age.
The severe ﬁndings in our patient clearly reﬂect the devastating
clinical course and cerebral deterioration thatmay evolve in Alpers
syndrome. Our data indicate that not only liver failure but also
severe brain damage may contribute to death in Alpers syndrome.
In patients with POLG1 mutations, prolonged convulsive status
epilepticus is a common and fatal complication and represents a
major cause of death in these disease entities (Engelsen et al.).10
Focal epileptic seizures that often result in generalized status
epilepticus are characteristic symptoms of brain affection in Alpers
syndrome; however, they result in further cerebral damage
themselves thus creating a vicious cycle of central nervous system
pathology. In our patient, brainstem affection may have further
contributed to death potentially leading to central respiratory and
autonomic failure. Intriguingly, histochemical and molecularge-
netic postmortem analyses gave evidence of serious liver
dysfunction without conclusive clinical or morphological evidence
for fatal liver failure like ﬁbrosis, cirrhosis, or hepatic micro-vesicular steatosis as usually seen in hepatic failure due to
valproate treatment. We postulate that severe mtDNA depletion in
liver tissue resulted in respiratory chain dysfunction which was
reﬂected by severe COX-negativity of the liver tissue. Biochemical
liver dysfunction in our patient obviously did not yet lead to
relevant clinical signs or severe morphological tissue changes.
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